LXRX
NASDAQ · Pharmaceuticals
Lexicon Pharmaceuticals Inc
$2.01
-0.03 (-1.47%)
Open$2.04
Previous Close$2.04
Day High$2.10
Day Low$1.98
52W High$2.53
52W Low$0.70
Volume—
Avg Volume2.13M
Market Cap892.83M
P/E Ratio—
EPS$-0.07
SectorPharmaceuticals
Analyst Ratings
Buy
11 analysts
Price Target
+794.0% upside
Current
$2.01
$2.01
Target
$17.97
$17.97
$15.16
$17.97 avg
$22.64
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 63.80M | 68.34M | 62.90M |
| Net Income | -64,498,006 | 19.40M | 18.23M |
| Profit Margin | -101.1% | 28.4% | 29.0% |
| EBITDA | -61,847,403 | 29.54M | 28.34M |
| Free Cash Flow | — | 10.65M | 12.86M |
| Rev Growth | +692.7% | +10.7% | +9.3% |
| Debt/Equity | 0.50 | 0.92 | 0.73 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |